Cellipont Bioservices
Cell Therapy CDMO
- Headquarters
- Texas
- Employees
- 51–200
- Business Model
- B2B
- Website
- cellipont.com
- Last Round
- Venture RoundNov 2024
- Rounds
- 2
About
Contract development and manufacturing organization (CDMO) specializing in cell therapy development, analytics, and cGMP manufacturing.
Summary
Cellipont Bioservices is a Biotech company based in United States. Its most recent funding was a Venture Round in Nov 2024. Investors include HealthQuest Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2024
Sign up to see all 2 events
Funding: Growth Equity through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cellipont-bioservices"><img src="https://indexed.vc/api/badge/company/cellipont-bioservices" alt="Cellipont Bioservices on Indexed.vc" width="260" height="76" /></a>